These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7775190)

  • 1. Improvement of decreased critical flicker frequency (CFF) in headache patients with drug abuse after successful withdrawal.
    Schnider P; Maly J; Grünberger J; Aull S; Zeiler K; Wessely P
    Headache; 1995 May; 35(5):269-72. PubMed ID: 7775190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMPI and critical flicker frequency (CFF) analysis in headache patients with and without drug abuse.
    Schnider P; Maly J; Mraz M; Brantner-Inthaler S; Zeiler K; Wessely P
    Headache; 1995 Jan; 35(1):17-20. PubMed ID: 7868329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up.
    Schnider P; Aull S; Baumgartner C; Marterer A; Wöber C; Zeiler K; Wessely P
    Cephalalgia; 1996 Nov; 16(7):481-5; discussion 461. PubMed ID: 8933992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Headache caused by analgesic and/or ergotamine abuse].
    Panconesi A; Del Bianco PL; Curradi C; Franchi G; Anselmi B; Andreini R
    Clin Ter; 1991 May; 137(3):169-83. PubMed ID: 1831085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular adaptation in migraineurs with chronic daily headache.
    Hering R; Gardiner I; Catarci T; Whitmarsh T; Steiner T; de Belleroche J
    Cephalalgia; 1993 Aug; 13(4):261-6. PubMed ID: 8397071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of ergotamine-induced headache and ergotamine withdrawal on information processing.
    Evers S; Schmidt F; Bauer B; Voss H; Grotemeyer KH; Husstedt IW
    Psychopharmacology (Berl); 1999 Feb; 142(1):61-7. PubMed ID: 10102783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse.
    Fritsche G; Eberl A; Katsarava Z; Limmroth V; Diener HC
    Eur Neurol; 2001; 45(4):229-35. PubMed ID: 11385260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.
    Hering R; Steiner TJ
    Lancet; 1991 Jun; 337(8755):1442-3. PubMed ID: 1675320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations.
    Ala-Hurula V; Myllylä V; Hokkanen E
    Cephalalgia; 1982 Dec; 2(4):189-95. PubMed ID: 7159921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial Doppler ultrasonographic features during drug withdrawal from drug-induced headache. A transcranial Doppler follow-up study.
    Haase CG; Diener HC
    Headache; 1998 Oct; 38(9):679-83. PubMed ID: 15613180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Headache from overuse of medication].
    Meienberg O
    Ther Umsch; 2006 Mar; 63(3):205-10. PubMed ID: 16613292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache.
    Hering-Hanit R; Gadoth N; Cohen A; Horev Z
    J Child Neurol; 2001 Jun; 16(6):448-9. PubMed ID: 11417614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug abuse in chronic headache: a clinico-epidemiologic study.
    Granella F; Farina S; Malferrari G; Manzoni GC
    Cephalalgia; 1987 Mar; 7(1):15-9. PubMed ID: 3581158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.
    Zeeberg P; Olesen J; Jensen R
    Cephalalgia; 2006 Oct; 26(10):1192-8. PubMed ID: 16961785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term prognosis of analgesics abuse headache].
    Takase Y; Kishigami H; Nakano M; Tatsumi C
    Rinsho Shinkeigaku; 2005 Sep; 45(9):629-33. PubMed ID: 16248393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of withdrawal headache following overuse of triptans and other headache drugs.
    Katsarava Z; Fritsche G; Muessig M; Diener HC; Limmroth V
    Neurology; 2001 Nov; 57(9):1694-8. PubMed ID: 11706113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache.
    Trucco M; Meineri P; Ruiz L;
    J Headache Pain; 2005 Sep; 6(4):334-7. PubMed ID: 16362704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up.
    Zidverc-Trajkovic J; Pekmezovic T; Jovanovic Z; Pavlovic A; Mijajlovic M; Radojicic A; Sternic N
    Cephalalgia; 2007 Nov; 27(11):1219-25. PubMed ID: 17888081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic-induced chronic headache: long-term results of withdrawal therapy.
    Diener HC; Dichgans J; Scholz E; Geiselhart S; Gerber WD; Bille A
    J Neurol; 1989 Jan; 236(1):9-14. PubMed ID: 2915233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache.
    Diener HC; Haab J; Peters C; Ried S; Dichgans J; Pilgrim A
    Headache; 1991 Apr; 31(4):205-9. PubMed ID: 1646775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.